124 related articles for article (PubMed ID: 1351056)
1. Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation.
Peles E; Lamprecht R; Ben-Levy R; Tzahar E; Yarden Y
J Biol Chem; 1992 Jun; 267(17):12266-74. PubMed ID: 1351056
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma.
Peles E; Levy RB; Or E; Ullrich A; Yarden Y
EMBO J; 1991 Aug; 10(8):2077-86. PubMed ID: 1676673
[TBL] [Abstract][Full Text] [Related]
3. An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.
Ben-Levy R; Peles E; Goldman-Michael R; Yarden Y
J Biol Chem; 1992 Aug; 267(24):17304-13. PubMed ID: 1355090
[TBL] [Abstract][Full Text] [Related]
4. A chimeric EGFR/neu receptor in functional analysis of the neu oncoprotein.
Lehtola L; Lehväslaiho H; Koskinen P; Alitalo K
Acta Oncol; 1992; 31(2):147-50. PubMed ID: 1352454
[TBL] [Abstract][Full Text] [Related]
5. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
Besset V; Scott RP; Ibáñez CF
J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
[TBL] [Abstract][Full Text] [Related]
6. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
[TBL] [Abstract][Full Text] [Related]
7. Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy.
Stancovski I; Peles E; Ben Levy R; Lemprecht R; Kelman Z; Goldman-Michael R; Hurwitz E; Bacus S; Sela M; Yarden Y
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):95-103. PubMed ID: 1356018
[TBL] [Abstract][Full Text] [Related]
8. Activation of phosphatidylinositol-3 kinase by nerve growth factor involves indirect coupling of the trk proto-oncogene with src homology 2 domains.
Ohmichi M; Decker SJ; Saltiel AR
Neuron; 1992 Oct; 9(4):769-77. PubMed ID: 1382475
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphatase inhibition permits analysis of signal transduction complexes in p185HER2/neu-overexpressing human tumor cells.
Jallal B; Schlessinger J; Ullrich A
J Biol Chem; 1992 Mar; 267(7):4357-63. PubMed ID: 1347042
[TBL] [Abstract][Full Text] [Related]
10. A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells.
Piccinini G; Bacchiocchi R; Serresi M; Vivani C; Rossetti S; Gennaretti C; Carbonari D; Fazioli F
J Biol Chem; 2002 Jun; 277(25):22231-9. PubMed ID: 11919185
[TBL] [Abstract][Full Text] [Related]
11. Specific association of the beta isoform of the p85 subunit of phosphatidylinositol-3 kinase with the proto-oncogene c-cbl.
Hartley D; Meisner H; Corvera S
J Biol Chem; 1995 Aug; 270(31):18260-3. PubMed ID: 7629144
[TBL] [Abstract][Full Text] [Related]
12. p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase.
Panchamoorthy G; Fukazawa T; Miyake S; Soltoff S; Reedquist K; Druker B; Shoelson S; Cantley L; Band H
J Biol Chem; 1996 Feb; 271(6):3187-94. PubMed ID: 8621719
[TBL] [Abstract][Full Text] [Related]
13. Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase.
Lev S; Givol D; Yarden Y
Proc Natl Acad Sci U S A; 1992 Jan; 89(2):678-82. PubMed ID: 1370584
[TBL] [Abstract][Full Text] [Related]
14. The protein-tyrosine kinase fer associates with signaling complexes containing insulin receptor substrate-1 and phosphatidylinositol 3-kinase.
Iwanishi M; Czech MP; Cherniack AD
J Biol Chem; 2000 Dec; 275(50):38995-9000. PubMed ID: 11006284
[TBL] [Abstract][Full Text] [Related]
15. Biochemical comparisons of the normal and oncogenic forms of insect cell-expressed neu tyrosine kinases.
Guy PM; Carraway KL; Cerione RA
J Biol Chem; 1992 Jul; 267(20):13851-6. PubMed ID: 1352772
[TBL] [Abstract][Full Text] [Related]
16. p120cbl is a cytosolic adapter protein that associates with phosphoinositide 3-kinase in response to epidermal growth factor in PC12 and other cells.
Soltoff SP; Cantley LC
J Biol Chem; 1996 Jan; 271(1):563-7. PubMed ID: 8550620
[TBL] [Abstract][Full Text] [Related]
17. An incomplete program of cellular tyrosine phosphorylations induced by kinase-defective epidermal growth factor receptors.
Wright JD; Reuter CW; Weber MJ
J Biol Chem; 1995 May; 270(20):12085-93. PubMed ID: 7538132
[TBL] [Abstract][Full Text] [Related]
18. Heregulin-dependent activation of phosphoinositide 3-kinase and Akt via the ErbB2/ErbB3 co-receptor.
Hellyer NJ; Kim MS; Koland JG
J Biol Chem; 2001 Nov; 276(45):42153-61. PubMed ID: 11546794
[TBL] [Abstract][Full Text] [Related]
19. Demonstration by two-color flow cytometry that tyrosine kinase activity is required for down-modulation of the oncogenic neu receptor.
Brown VI; Shah N; Smith R; Hellman M; Jarett L; Mikami Y; Cohen E; Qian X; Greene MI
DNA Cell Biol; 1994 Feb; 13(2):193-209. PubMed ID: 7910024
[TBL] [Abstract][Full Text] [Related]
20. Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells.
Hennige AM; Lammers R; Arlt D; Höppner W; Strack V; Niederfellner G; Seif FJ; Häring HU; Kellerer M
Mol Cell Endocrinol; 2000 Sep; 167(1-2):69-76. PubMed ID: 11000521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
